Bisoprolol Fumarate

富马酸比索洛尔

Report date: 2023/08/10 16:08:37
NME

Base Information

Drug NameBisoprolol Fumarate
Drug Alias Name比索洛尔-富马酸Bisoprololum比索萝尔毕索洛尔比索咯尔 +[21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsFastingEssential HypertensionHypertension +[7
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryGermany
Original Approved Date1986/01/30
Country/TerritoryUnited StatesNew ZealandAustralia +[8
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Other Information

ATC CodeC07AB07